規模化缺口也是證據配置問題

新創規模化差距不只涉及資本或發明數量，也涉及技術、商業、治理與營運證據能否在關鍵階段到達正確決策者。 OECD 對近 20 萬家歐盟與美國創新企業的研究，把規模化問題從單純資本不足推進到不同階段需要何種證據。專利能證明一部分技術資產，卻不能單獨證明客戶採用、單位經濟、管理能力或跨境交付。企業可能技術已準備，制度上仍無法支援晚期決策者依賴。 本期 Signal 將 新創規模化差距背後的證據配置問題 視為多個制度行動逐步收斂的方向，而不是任何一個機構已宣布的共同計畫。各訊號的法律地位、發布時間與適用對象仍須分列，交叉閱讀只能支持方向判斷，不能把相似語言改寫成統一義務。 為使摘要能直接支援決策，本段同時回答五個問題：已發生什麼、由哪一第一方紀錄支持、影響透過什麼機制傳導、目前仍缺少哪些結果證據，以及下一個可推翻或強化判斷的檢查點。任何未被來源明示的因果關係都保留為編輯推論，不以肯定語氣包裝。

The scale-up gap concerns more than capital or invention. It also concerns whether technical, commercial, governance and operating evidence reaches the right decision-maker at each transition. The OECD study of almost 200,000 innovative EU and US firms moves scale-up beyond a simple shortage of capital toward the evidence required at different stages. A patent establishes part of a technical asset but cannot independently prove customer adoption, unit economics, management capability or cross-border delivery. A company may be technically ready while institutionally unable to support late-stage reliance. This Signal treats the evidence-allocation problem beneath the start-up scale-up gap as a direction emerging across institutional actions, not as a joint programme announced by any one authority. Legal status, publication date and population remain source-specific. Cross-reading supports a directional judgement only; similar language must not be converted into a single obligation. To make the lead decision-ready, it answers five questions together: what has occurred, which first-party record supports it, through what mechanism the effect may travel, which outcome evidence is still missing, and what next observation could strengthen or overturn the judgement. Any causal relationship not stated by the source remains an editorial inference and is not converted into a factual claim through confident wording.

OECD 研究涵蓋 2000 至 2025 年近 20 萬家歐盟與美國創新企業，分析專利、融資、收購、管理專業化與生態系外溢。 早期投資人、成長資本、收購方、銀行、董事會與海外客戶使用不同判斷。首次專利、營收成長、治理專業化、財務長聘任與收購路徑是不同訊號；把它們放在同一分數，會掩蓋哪一證據對哪一規模化決策真正重要。 訊號收斂的判斷基礎不是關鍵字相似，而是不同制度是否開始要求相近的資料身分、來源、方法、責任、控制與版本能力。每筆來源仍保留自己的治理權限與時間點，避免把跨機構比較誤讀成制度合併。 時間與權限也必須分開記錄：公告日不等於生效日，試點不等於普遍採用，技術規格不等於法律義務，企業自願導入也不等於監理核准。把這些節點放在同一時間軸，才能判斷一項制度變動何時真正進入資料、合約、投資或揭露流程。

The OECD study covers nearly 200,000 innovative EU and US ventures founded from 2000 to 2025 and examines patents, finance, acquisitions, professionalization and spillovers. Early investors, growth capital, acquirers, banks, boards and overseas customers make different judgements. First patent, revenue growth, management professionalisation, appointment of a CFO and acquisition pathways are different signals. One composite score conceals which evidence matters to which scale-up decision. Convergence is not established by repeated vocabulary. It is established when independent institutions begin to require comparable capabilities around identity, origin, method, accountability, control and version. Every source retains its own authority and time reference so that comparison does not become a claim of institutional merger. Time and authority must also be separated. An announcement date is not an effective date; a pilot is not general adoption; a technical specification is not a legal obligation; and voluntary enterprise use is not regulatory approval. Putting these events on one timeline shows when an institutional development actually enters data, contract, investment or disclosure processes and which actor is authorised to make that transition.

歐洲取得專利的新創在部分發明表現不弱，但從首次專利到規模化平均多約 1.49 年。發明證據不能直接證明市場採用、財務紀律或跨境執行能力。 主要斷點發生在發明之後。研發團隊擁有技術證明，商業團隊的客戶與合約紀錄尚未結構化，財務與治理資料又可能為內部目的形成。當晚期投資或跨境合作需要整體判斷，企業只能以敘事補足，增加盡職調查時間與不確定性。 上游證據若沒有穩定識別、形成時間、適用邊界與版本，最終輸出即使格式一致，覆核者仍可能無法重建形成過程。真正風險不是單一欄位缺失，而是錯誤主體、過期方法、推定關係或未核准版本在傳遞中被當成確定事實。 具體失效模式至少包括主體配對錯誤、資料人口不完整、邊界前後不一致、方法或係數未版本化、例外未留下理由、核准與發布時間倒置，以及下游重用時脫離原用途。每一種失效都可能讓合理的單筆資料，在彙總後形成無法防禦的結論。

European patenting ventures are not uniformly weaker inventors, yet the path from first patent to scale is about 1.49 years longer. Invention does not prove market adoption or institutional readiness. The main discontinuity occurs after invention. Research teams hold technical proof, customer and contract records remain unstructured in commercial teams, and finance and governance data were formed for internal purposes. When late-stage investment or cross-border partnership requires a whole-enterprise judgement, narrative substitutes for evidence and lengthens due diligence. When upstream evidence lacks stable identity, formation time, applicable boundary and version, a standardised output may still be impossible to reconstruct. The material risk is not one missing field. It is the silent conversion of the wrong entity, an expired method, an inferred relationship or an unapproved version into an apparent fact as information moves downstream. Concrete failure modes include incorrect entity matching, an incomplete data population, inconsistent boundaries, unversioned methods or factors, exceptions without rationale, approval occurring after publication, and downstream reuse outside the original purpose. Each failure can turn a reasonable individual record into a conclusion that cannot be defended after aggregation, comparison or machine-assisted interpretation.

規模化需讓商業牽引、財務績效、治理準備、管理能力與跨司法管轄區證據，依決策階段轉為可理解、可驗證且可依賴的資訊。 Evidence allocation 應依決策階段配置技術、智慧財產、市場牽引、單位經濟、治理、團隊、合規與交付證據，為每項資料標示來源、期間、覆核與允許用途。相同證據可以重用，但投資、收購或客戶決策需要不同組合與強度。 可執行的控制單位應是受治理的證據物件：每項重要主張連接原始來源、計算或判斷方法、組織與時間邊界、責任人、控制狀態、例外、核准及版本。當任何元件改變時，系統保存差異與影響範圍，不以覆寫舊檔取代變更紀錄。 營運上可建立最小控制集：主張登錄、證據擁有人、來源快照、方法識別、適用期間、控制頻率、例外門檻、覆核與核准，以及允許的下游用途。高判斷或高財務影響項目採更嚴格的覆核層級；低風險資料則以自動化完整性檢查降低重工。

Scaling requires commercial traction, financial performance, governance readiness, management capability and cross-jurisdiction evidence to become understandable, verifiable and reliable. Evidence allocation maps technical, intellectual-property, market-traction, unit-economics, governance, team, compliance and delivery evidence to decision stage, with source, period, review and permitted use. Evidence can be reused, but investment, acquisition and customer decisions require different combinations and strength. The implementable control unit is a governed evidence object. Each material claim links to its primary source, calculation or judgement method, organisational and temporal boundary, accountable owner, control state, exception, approval and version. When any component changes, the system preserves the difference and affected uses instead of overwriting the earlier basis. A minimum operating control set includes a claim register, evidence owner, source snapshot, method identity, valid period, control frequency, exception threshold, review, approval and permitted downstream use. High-judgement or high-financial-impact items receive a stronger review tier. Lower-risk records use automated completeness and consistency checks so that governance effort is concentrated where a wrong claim would change a decision.

OECD 發現顯示差距在發明之後擴大，晚期資本、收購路徑與外部財務長等專業化訊號，都與規模化速度及能力有關。 OECD 研究支持樣本、歐盟與美國比較、規模化時間及管理專業化等觀察；它不能證明任何單一證據會因果地保證企業成功。SNN 把研究結果解讀為證據配置問題，是制度分析，不是投資建議或新創評分模型。 證據判讀採來源對照而非票數累加。多筆文件若都引用同一基礎資料，仍只構成一條證據路徑；不同機構出現相近要求，則可提高方向性訊號，但不能證明執行成效、法律等同性或所有市場已同步成熟。 每一項關鍵句都應進入 claim ledger，標示其為官方事實、直接量測、估算、企業承諾、已交付結果或 SNN 編輯推論，並記錄來源所能支持的精確範圍。若兩筆來源衝突，保留衝突與處理理由；若資料尚未出現，明確標成待驗證，而不是以相近案例補成確定答案。

OECD findings show divergence after invention, with late-stage capital, acquisition pathways and professionalization signals such as an external CFO associated with scaling dynamics. The OECD research supports sample, EU-US comparison, scale-up timing and management-professionalisation observations. It cannot establish that any one item causally guarantees success. SNN's interpretation as an evidence-allocation problem is institutional analysis, not investment advice or a start-up scoring model. Evidence is assessed through source comparison rather than a simple source count. Documents that repeat one underlying dataset remain one evidential path. Similar requirements from independent institutions can strengthen a directional signal, but they do not prove implementation results, legal equivalence or equal market maturity. Every material sentence should enter a claim ledger and be classified as official fact, direct measurement, estimate, corporate commitment, delivered outcome or SNN editorial inference. The ledger records the precise scope that each source supports. Conflicting evidence is retained with the resolution rationale; absent evidence is marked pending rather than filled with a convenient analogue from another entity, period or jurisdiction.

資本配置越重大，所需證據越廣。企業可能技術上已準備好，制度上卻尚未能支援投資人、董事會與跨境機構的依賴。 這項訊號顯示生態系政策不能只增加早期創業數量，也需要支援企業把技術轉成可供晚期資本與跨境市場使用的證據。專業管理、標準化財務、治理與交易紀錄會降低決策摩擦，並在收購或人才流動後形成可傳遞的生態系能力。 這種資訊密度的目的不是增加篇幅，而是縮短主張到決策之間的查核距離。董事會、投資人、監理者與營運團隊應能辨識哪些內容是事實、估算、承諾、進度或結果，並在情境改變時更新判斷，而不是重新尋找散落的檔案與口頭說明。 責任分工因此必須落到決策權：資料擁有人維護來源，方法擁有人控制計算，業務單位說明使用情境，內控或確信人員測試可重建性，核准者承擔最終採用責任。例外若沒有到期日、補救人與影響範圍，就會從暫時處置變成永久的證據債務。

More consequential capital decisions require broader evidence. A venture can be technically ready before it is institutionally ready for investor, board and cross-border reliance. The signal suggests that ecosystem policy should not increase only early-stage firm formation. It should help companies convert technology into evidence usable by later capital and cross-border markets. Professional management, standardised finance, governance and transaction records reduce decision friction and create transferable ecosystem capability after acquisition or talent movement. The purpose of this information density is not length for its own sake. It is to shorten the verification distance between claim and decision. Boards, investors, regulators and operational teams should be able to distinguish fact, estimate, commitment, progress and outcome, then update the judgement when conditions change without reconstructing the case from scattered files and oral explanation. Accountability therefore attaches to decision rights. The data owner maintains the source, the method owner controls calculation, the business function defines the use case, internal control or assurance tests reproducibility, and the approver accepts responsibility for final use. An exception without an expiry date, remediation owner and impact scope stops being temporary treatment and becomes persistent evidence debt.

SNN 編輯分析：歐洲與全球規模化研究對台灣 AI、半導體、生醫與永續科技新創的啟示，不只是增加早期資金，而是把技術展示轉成海外客戶、投資人與策略夥伴可依賴的成長證據。市場牽引、單位經濟、智慧財產、治理、法遵與跨境交付紀錄必須配置到正確決策階段。 台灣 AI、半導體、生醫與永續科技新創常有強技術與補助紀錄，海外投資人及客戶卻需要市場採用、IP 權利、法遵、治理與跨境交付。企業應從早期就保存可驗證的客戶里程碑、單位經濟、董事會決策與權利鏈，避免在募資或策略合作時才以簡報重建。 對台灣市場的意義應沿實際傳導路徑判斷：國際制度或客戶要求先進入融資、採購、合約、供應商資料與確信流程，再影響台灣企業的系統與控制。這不等於外國規則自動成為台灣法律義務；本地企業要做的是辨識適用情境、保留跨語言對應並建立可授權覆核的證據鏈。 台灣企業可把傳導測試落在具體物件：公司與法律主體、廠區、產品、批次、供應商、合約、融資工具及揭露欄位。中英文名稱、內外部分類與不同框架之間應連到同一主張識別，同時保留商業機密、個資與權限邊界，避免可追溯被誤解為全面公開。

SNN editorial analysis: European and global scale-up research suggests that Taiwan AI, semiconductor, biotech and sustainability startups need more than early capital. They must convert demonstrations into growth evidence for international customers, investors and partners, with traction, unit economics, IP, governance, compliance and cross-border delivery matched to each decision stage. Taiwan AI, semiconductor, biotech and sustainability start-ups often have strong technology and grant records, while overseas investors and customers need adoption, IP rights, compliance, governance and delivery evidence. Verified customer milestones, unit economics, board decisions and chains of title should be preserved early instead of reconstructed in a pitch deck during fundraising. For Taiwan, relevance should be traced through an actual transmission path. An international rule or customer requirement first enters finance, procurement, contract, supplier-data and assurance processes, then changes local systems and controls. It does not automatically become Taiwan law. Companies need to identify the applicable scenario, preserve bilingual mappings and make the evidence chain reviewable under controlled access. Taiwan companies can perform the transmission test on concrete objects: the company and legal entity, facility, product, batch, supplier, contract, financing instrument and disclosure field. Chinese and English names, internal and external classifications and different reporting frameworks should resolve to the same claim identity. Traceability must still preserve commercial confidentiality, personal data and access boundaries; it does not require unrestricted publication.

後續應觀察企業如何把個別成功轉為可傳遞的人才、供應商、投資知識與商業化能力，形成生態系基礎設施。 後續應觀察台灣與其他市場的晚期資本、收購與專業管理如何影響規模化。低後悔行動是為下一個重大決策建立 evidence readiness matrix，列出決策者、必要主張、支持證據、缺口與責任人，並在正式盡職調查前由外部視角測試。 後續追蹤應分開最終文件、技術指引、採用範圍、執行控制、監督活動與可觀察結果。現階段的低後悔行動，是挑選一項高風險主張做端到端重建測試，記錄缺少的身分、來源、方法、責任與版本；這是治理準備，不是合規保證或結果預測。 監測不只依日曆，而應由事件觸發：最終規則發布、技術指引變更、適用範圍擴大、主管機關執法、企業採用數據或實際成果出現時，都建立新版本並重評原判斷。舊結論不刪除，而是標示當時依據、被何種新證據修正，以及哪些決策需要重新檢視。

Future evidence should show how individual success becomes transferable talent, supplier capability, investor knowledge and commercialization infrastructure across an ecosystem. Future evidence should examine how late-stage capital, acquisition and professional management affect scaling in Taiwan and other markets. A low-regret action is an evidence-readiness matrix for the next material decision, identifying decision-maker, required claim, supporting evidence, gap and owner and testing it from an external perspective before due diligence. Future monitoring should separate final text, technical guidance, adoption scope, operating controls, supervision and observable outcomes. A low-regret step is to select one high-risk claim for an end-to-end reconstruction test and record missing identity, source, method, accountability and version. That is governance preparation, not a compliance guarantee or forecast of results. Monitoring should be event-triggered as well as calendar-based. A final rule, amended technical guidance, expanded scope, supervisory action, adoption data or observed outcome creates a new version and a reassessment of the earlier judgement. The prior conclusion is not erased. It retains its original basis, identifies the new evidence that changed it and states which decisions or downstream uses now require review.